Terms: = Breast cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
78 results:
1. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
[TBL] [Abstract] [Full Text] [Related]
2. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
Schwartz CJ; Krings G; Chen YY
Histopathology; 2024 Jan; 84(2):409-411. PubMed ID: 37706238
[TBL] [Abstract] [Full Text] [Related]
3. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.
Jorns JM; Farooq A; Puzyrenko A; Jarzembowski J; Thike AA; Nasir NDM; Ng CCY; Liu W; Lee JY; Lim AH; Guan P; Teh BT; Tan PH
Histopathology; 2023 Sep; 83(3):357-365. PubMed ID: 37140543
[TBL] [Abstract] [Full Text] [Related]
4. Periductal Stromal Tumor of the breast with a
Anderson B; Marotti JD; Lefferts JA; Muller KE
Int J Surg Pathol; 2023 Dec; 31(8):1626-1631. PubMed ID: 36823780
[TBL] [Abstract] [Full Text] [Related]
5. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
[TBL] [Abstract] [Full Text] [Related]
8. Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma.
Yasutake N; Iwasaki T; Yamamoto H; Sonoda K; Kodama K; Okugawa K; Asanoma K; Yahata H; Kato K; Oda Y
Pathol Res Pract; 2022 Jul; 235():153920. PubMed ID: 35605413
[TBL] [Abstract] [Full Text] [Related]
9. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
Seow DYB; Tay TKY; Tan PH
Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
[TBL] [Abstract] [Full Text] [Related]
10. High-Grade Spindle Cell Lesions of the breast: Key Pathologic and Clinical Updates.
Yoon E; Ding Q; Hunt K; Sahin A
Surg Pathol Clin; 2022 Mar; 15(1):77-93. PubMed ID: 35236635
[TBL] [Abstract] [Full Text] [Related]
11. Role of the Mediator Complex and MicroRNAs in breast cancer Etiology.
Maldonado E; Morales-Pison S; Urbina F; Jara L; Solari A
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205279
[TBL] [Abstract] [Full Text] [Related]
12. med12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.
Hu Y; Li G; Wang L; Zhang L; Guan J; Wang J
Pathol Int; 2021 Dec; 71(12):814-822. PubMed ID: 34597441
[TBL] [Abstract] [Full Text] [Related]
13. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract] [Full Text] [Related]
14. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
Zhou P; Zhang Q; Zhu J; Li P
Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases.
Chao X; Tan W; Tsang JY; Tse GM; Hu J; Li P; Hou J; Li M; He J; Sun P
Breast Cancer; 2021 Sep; 28(5):1100-1111. PubMed ID: 33942253
[TBL] [Abstract] [Full Text] [Related]
16. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.
Ng CCY; Md Nasir ND; Loke BN; Tay TKY; Thike AA; Rajasegaran V; Liu W; Lee JY; Guan P; Lim AH; Chang KTE; Gudi MA; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Yip GWC; Bay BH; Tan P; Teh BT; Tan PH
Mod Pathol; 2021 Jul; 34(7):1320-1332. PubMed ID: 33727697
[TBL] [Abstract] [Full Text] [Related]
17. Stromal
da Silva EM; Beca F; Sebastiao APM; Murray MP; Silveira C; Da Cruz Paula A; Pareja F; Wen HY; D'Alfonso TM; Edelweiss M; Weigelt B; Brogi E; Reis-Filho JS; Zhang H
J Clin Pathol; 2022 Feb; 75(2):133-136. PubMed ID: 33376197
[TBL] [Abstract] [Full Text] [Related]
18. Detection of med12 mutations in mesenchymal components of uterine adenomyomas.
Kito M; Maeda D; Kudo-Asabe Y; Tamura D; Makino K; Sageshima M; Nanjo H; Terada Y; Goto A
Hum Pathol; 2021 Mar; 109():31-36. PubMed ID: 33259844
[TBL] [Abstract] [Full Text] [Related]
19. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of med12 mutations.
Otsuji K; Sasaki T; Tanabe M; Seto Y
Br J Cancer; 2021 Jan; 124(2):466-473. PubMed ID: 33046803
[TBL] [Abstract] [Full Text] [Related]
20. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
[Next]
